{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:46:17Z","timestamp":1792813577937,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["540-2013-8797"],"award-info":[{"award-number":["540-2013-8797"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["81361138019"],"award-info":[{"award-number":["81361138019"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81361138019"],"award-info":[{"award-number":["81361138019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874273"],"award-info":[{"award-number":["81874273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20150508"],"award-info":[{"award-number":["20150508"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jchromb.2020.122397","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:15:59Z","timestamp":1602144959000},"page":"122397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Development and validation of a simple LC-MS\/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma"],"prefix":"10.1016","volume":"1158","author":[{"given":"Xubin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin M.","family":"Jongedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Kuhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Niward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Paues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Davies Forsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2020.122397_b0005","unstructured":"World Health Organization, Global Tuberculosis Report 2019. https:\/\/www.who.int\/tb\/publications\/global_report\/en\/, 2019 (Accessed 6 May 2020)."},{"key":"10.1016\/j.jchromb.2020.122397_b0010","unstructured":"World Health Organization, United Nations High-Level Meeting on the fight to end tuberculosis. https:\/\/www.who.int\/docs\/default-source\/un-high-level-meeting-on-tb\/unhlm-visualization-final.pdf, 2018 (Accessed 6 May 2020)."},{"key":"10.1016\/j.jchromb.2020.122397_b0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/resp.13304","article-title":"Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment","volume":"23","author":"Lange","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.jchromb.2020.122397_b0020","unstructured":"World Health Organization, WHO consolidated guidelines on drug-resistant tuberculosis treatment. https:\/\/www.who.int\/tb\/publications\/2019\/consolidated-guidelines-drug-resistant-TB-treatment\/en\/, 2019 (Accessed 6 May 2020)."},{"key":"10.1016\/j.jchromb.2020.122397_b0025","first-page":"275","article-title":"Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000\u20132004","volume":"14","author":"Bloss","year":"2010","journal-title":"Int. J. Tuberc. Lung D"},{"key":"10.1016\/j.jchromb.2020.122397_b0030","first-page":"3","article-title":"Ototoxicity of aminoglycoside drugs in tuberculosis treatment","volume":"43","author":"Voogt","year":"1996","journal-title":"S. Afr. J. Commun. Disord."},{"key":"10.1016\/j.jchromb.2020.122397_b0035","series-title":"Guidelines for the Prevention and control of multidrug-resistant tuberculosis","author":"Wang","year":"2012"},{"key":"10.1016\/j.jchromb.2020.122397_b0040","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cbdv.200490061","article-title":"Photophysical and phototoxic properties of the antibacterial fluoroquinolones levofloxacin and moxifloxacin","volume":"1","author":"Viola","year":"2004","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.jchromb.2020.122397_b0045","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/rccm.201303-0604OC","article-title":"Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis","volume":"188","author":"Koh","year":"2013","journal-title":"Am. J. Resp. Crit. Care"},{"key":"10.1016\/j.jchromb.2020.122397_b0050","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2147\/PPA.S219920","article-title":"Drug non-adherence and reasons among multidrug-resistant tuberculosis patients in Guizhou, China: A cross-sectional study","volume":"13","author":"Wang","year":"2019","journal-title":"Patient Prefer Adher."},{"key":"10.1016\/j.jchromb.2020.122397_b0055","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/17425255.2016.1162785","article-title":"Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis","volume":"12","author":"Zuur","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122397_b0060","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","article-title":"Treatment of drug-resistant tuberculosis. An official ATS\/CDC\/ERS\/IDSA clinical practice guideline","volume":"200","author":"Nahid","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jchromb.2020.122397_b0065","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1086\/424849","article-title":"Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling","volume":"190","author":"Gumbo","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jchromb.2020.122397_b0070","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1093\/cid\/ciy611","article-title":"Levofloxacin pharmacokinetics\/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis","volume":"67","author":"Deshpande","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2020.122397_b0075","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/AAC.01681-08","article-title":"Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs","volume":"53","author":"Gumbo","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2020.122397_b0080","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1086\/651377","article-title":"Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol","volume":"201","author":"Srivastava","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jchromb.2020.122397_b0085","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1093\/cid\/ciy609","article-title":"Ethionamide pharmacokinetics\/pharmacodynamics-derived dose, the role of MICs in clinical outcome, and the resistance arrow of time in multidrug-resistant tuberculosis","volume":"67","author":"Deshpande","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2020.122397_b0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5588\/ijtld.18.0622","article-title":"Management of patients with multidrug-resistant tuberculosis","volume":"23","author":"Lange","year":"2019","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.jchromb.2020.122397_b0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/34.3.135","article-title":"Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method","volume":"34","author":"Pranger","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122397_b0100","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/AAC.00276-15","article-title":"Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry","volume":"59","author":"Alffenaar","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2020.122397_b0105","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.4155\/bio.14.191","article-title":"Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS\/MS method","volume":"6","author":"Dijkstra","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2020.122397_b0110","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s00216-017-0249-2","article-title":"A simplified LC-MS\/MS method for rapid determination of cycloserine in small-volume human plasma using protein precipitation coupled with dilution techniques to overcome matrix effects and its application to a pharmacokinetic study","volume":"409","author":"Mao","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2020.122397_b0115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3343\/alm.2016.36.5.489","article-title":"Multiplex assay of second-line anti-tuberculosis drugs in dried blood spots using ultra-performance liquid chromatography-tandem mass spectrometry","volume":"36","author":"Lee","year":"2016","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.jchromb.2020.122397_b0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpba.2014.08.026","article-title":"Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"102","author":"Kim","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122397_b0125","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/jac\/dkt154","article-title":"Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS\/MS","volume":"68","author":"Han","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jchromb.2020.122397_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1365\/s10337-010-1614-x","article-title":"The application of trichloroacetic acid as an ion pairing reagent in LC-MS-MS method development for highly polar aminoglycoside compounds","volume":"72","author":"Cheng","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2020.122397_b0135","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/AAC.03025-15","article-title":"Immunoassay analysis of kanamycin in serum using the tobramycin kit","volume":"60","author":"Dijkstra","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2020.122397_b0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0021-9673(04)01570-5","article-title":"Hydrophilic interaction chromatography combined with tandem-mass spectrometry to determine six aminoglycosides in serum","volume":"1058","author":"Oertel","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2020.122397_b0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis: an update","volume":"74","author":"Alsultan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2020.122397_b0150","unstructured":"Food and Drug Administration, Bioanalytical Method Validation Guidance for Industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry, 2018 (Accessed 6 May 2020)."},{"key":"10.1016\/j.jchromb.2020.122397_b0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/j.1552-4604.1994.tb03993.x","article-title":"Alternatives to least-squares linear-regression analysis for computation of standard curves for quantitation by high-performance liquid-chromatography - applications to clinical-pharmacology","volume":"34","author":"Szabo","year":"1994","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122397_b0160","unstructured":"European Medicines Agency, Guideline on bioanalytical method validation. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf, 2012 (Accessed 6 May 2020)."},{"key":"10.1016\/j.jchromb.2020.122397_b0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023899","article-title":"Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study","volume":"8","author":"Davies Forsman","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jchromb.2020.122397_b0170","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/rcm.2144","article-title":"Tandem mass spectrometry with online high-flow reversed-phase extraction and normal-phase chromatography on silica columns with aqueous-organic mobile phase for quantitation of polar compounds in biological fluids","volume":"19","author":"Deng","year":"2005","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2020.122397_b0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.chroma.2008.06.014","article-title":"Application of silica-based hyper-crosslinked sulfonate-modified reversed stationary phases for separating highly hydrophilic basic compounds","volume":"1202","author":"Luo","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2020.122397_b0180","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jssc.200600199","article-title":"Hydrophilic interaction chromatography","volume":"29","author":"Hemstrom","year":"2006","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2020.122397_b0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1570-0232(02)00914-5","article-title":"Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry","volume":"785","author":"Polson","year":"2003","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122397_b0190","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jpba.2005.05.022","article-title":"Evaluation of volatile ion-pair reagents for the liquid chromatography-mass spectrometry analysis of polar compounds and its application to the determination of methadone in human plasma","volume":"40","author":"Gao","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122397_b0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2885.2006.00720.x","article-title":"Use of tissue-fluid correlations to estimate gentamicin residues in kidney tissue of Holstein steers","volume":"29","author":"Chiesa","year":"2006","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122397_b0200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpba.2018.01.031","article-title":"Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS\/MS method","volume":"152","author":"Paal","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122397_b0205","doi-asserted-by":"crossref","first-page":"E353","DOI":"10.1208\/aapsj0903042","article-title":"Determination of carryover and contamination for mass spectrometry-based chromatographic assays","volume":"9","author":"Hughes","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2020.122397_b0210","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4155\/bio.09.91","article-title":"Assessing the matrix effects of hemolyzed samples in bioanalysis","volume":"1","author":"Hughes","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2020.122397_b0215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5588\/ijtld.14.0838","article-title":"Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000\u20132009","volume":"19","author":"van Altena","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.jchromb.2020.122397_b0220","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1183\/13993003.01208-2016","article-title":"Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly","volume":"48","author":"van Altena","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jchromb.2020.122397_b0225","doi-asserted-by":"crossref","unstructured":"Q. Lei, H. Wang, Y. Zhao, L.Y. Dang, C.S. Zhu, X.H. Lv, H. Wang, J. Zhou, Determinants of serum concentration of first-line anti-tuberculosis drugs from China, Medicine, 98 (2019). ARTN e17523 10.1097\/MD.0000000000017523.","DOI":"10.1097\/MD.0000000000017523"},{"key":"10.1016\/j.jchromb.2020.122397_b0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4046\/trd.2015.78.2.78","article-title":"Outcomes and use of therapeutic drug monitoring in multidrug-resistant tuberculosis patients treated in Virginia, 2009\u20132014","volume":"78","author":"Heysell","year":"2015","journal-title":"Tuberc. Respir. Dis."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220312733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220312733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:19:44Z","timestamp":1778620784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023220312733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":46,"alternative-id":["S1570023220312733"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122397","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a simple LC-MS\/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122397"}}